CSL Limited

ASX:CSL

CSL Limited

ASX:CSL
TradeAdd trade order Follow Unfollow Set Price Alert
$278.45 (-0.2%)
Last close price
#34
Rank
21
Held by
53
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (2) My Report Forum Investors
Top member reports
Consensus
Batten
Company Report
Last edited 4 years ago
PerformanceCommunity EngagementCommunity Endorsement
Performance (52m)
-8.2% pa
Followed by
20
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#ASX Announcements
stale
Batten
Added 4 years ago
View author's company report

CSL to Acquire Biotech Company Vitaeris

 

CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has agreed to exercise its right to acquire Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development of a treatment for rejection in solid organ kidney transplant patients. The companies entered into a strategic partnership in 2017 to expedite the development of this program with the option for CSL to acquire Vitaeris in full.

View Attachment